Leviticus Cardio
Improving the quality of life for future LVAD patients with reliable, wireless power.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
N/A | Grant | ||
| Total Funding | 000k | ||
Related Content
Leviticus Cardio specializes in developing advanced wireless power transfer solutions for patients with Congestive Heart Failure (CHF). Utilizing proprietary Coplanar Energy Transfer (CET) technology, the company integrates this system with existing Ventricular Assist Devices (VADs) to offer a robust and comprehensive hybrid solution. The CET system allows for high-efficiency power transfer of up to 30 Watts and is designed to be highly resistant to device misplacement and movement within the body. Patients benefit from up to 8 hours of freedom from external equipment, significantly improving their quality of life. Leviticus Cardio operates in the medical device market, targeting healthcare providers and CHF patients. The business model revolves around clinical trials and future commercialization of its innovative technology. Revenue is expected to be generated through sales of the CET system and associated support services.
Keywords: wireless power transfer, CHF, VAD, Coplanar Energy Transfer, medical device, high-efficiency, quality of life, clinical trials, healthcare, innovation.